{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:37:39Z","timestamp":1769107059796,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.amjcard.2023.06.105","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T12:57:31Z","timestamp":1690030651000},"page":"122-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment"],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0492-6241","authenticated-orcid":false,"given":"Jos\u00e9 Miguel","family":"Rivera-Caravaca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Anguita Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Sanmart\u00edn Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carles","family":"Rafols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Bar\u00f3n-Esquivias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Arribas Ynsaurriaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rom\u00e1n","family":"Freixa-Pamias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I\u00f1aki","family":"Lekuona Goya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manuel","family":"V\u00e1zquez Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro I.","family":"P\u00e9rez-Cabeza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Cos\u00edn-Sales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Ure\u00f1a Montilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"\u00c1lvarez-Vieitez Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2023.06.105_bib0001","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41569-020-00459-3","article-title":"Stroke prevention strategies in high-risk patients with atrial fibrillation","volume":"18","author":"Kotalczyk","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0002","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ccep.2020.11.003","article-title":"Atrial fibrillation and stroke","volume":"13","author":"Essa","year":"2021","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0003","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0004","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/cvr\/cvaa258","article-title":"Pathophysiology of atrial fibrillation and chronic kidney disease","volume":"117","author":"Ding","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ccep.2020.11.001","article-title":"Renal disease and atrial fibrillation","volume":"13","author":"Stefil","year":"2021","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0008","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10557-019-06885-x","article-title":"Oral anticoagulation for atrial fibrillation thromboembolism prophylaxis in the chronic kidney disease population: the state of the art in 2019","volume":"33","author":"Zhang","year":"2019","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0011","doi-asserted-by":"crossref","first-page":"e13745","DOI":"10.1111\/eci.13745","article-title":"Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry","volume":"52","author":"Ding","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0012","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1160\/TH17-06-0416","article-title":"Relation of renal dysfunction to quality of anticoagulation control in patients with atrial fibrillation: the FANTASIIA registry","volume":"118","author":"Esteve-Pastor","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0013","first-page":"867","article-title":"Chronic kidney disease and risks of adverse clinical events in patients with atrial fibrillation","volume":"18","author":"Li","year":"2021","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0014","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10557-021-07144-8","article-title":"Effect of rivaroxaban or apixaban in atrial fibrillation patients with Stage 4\u20135 chronic kidney disease or on dialysis","volume":"35","author":"Chen","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0015","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/STROKEAHA.120.028934","article-title":"Direct-acting oral anticoagulants versus warfarin in Medicare patients with chronic kidney disease and atrial fibrillation","volume":"51","author":"Wetmore","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0016","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/j.ajkd.2020.02.446","article-title":"Risk of cardiovascular events and mortality among elderly patients with reduced GFR receiving direct oral anticoagulants","volume":"76","author":"Ashley","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0017","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.amjcard.2019.10.033","article-title":"Safety and efficacy of direct oral anticoagulants versus warfarin in patients with chronic kidney disease and atrial fibrillation","volume":"125","author":"Makani","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0018","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ahj.2020.01.010","article-title":"Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV\u2013V chronic kidney disease","volume":"223","author":"Weir","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0019","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s40620-018-0501-7","article-title":"Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data","volume":"31","author":"Di Lullo","year":"2018","journal-title":"J Nephrol"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0020","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/jcph.1838","article-title":"The pharmacology, efficacy, and safety of rivaroxaban in renally impaired patient populations","volume":"61","author":"Ashton","year":"2021","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0021","doi-asserted-by":"crossref","first-page":"18942","DOI":"10.1038\/s41598-020-76098-y","article-title":"Using CHADS2 and CHA2DS2-VASc scores for mortality prediction in patients with chronic kidney disease","volume":"10","author":"Hsu","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0022","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s11739-021-02799-5","article-title":"Does CHA2DS2-VASc score predict mortality in chronic kidney disease?","volume":"16","author":"Goudis","year":"2021","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0023","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jjcc.2014.03.006","article-title":"Improvement of HAS-BLED bleeding score predictive capability by changing the definition of renal dysfunction in Japanese atrial fibrillation patients on anticoagulation therapy","volume":"64","author":"Suzuki","year":"2014","journal-title":"J Cardiol"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101527","article-title":"Impact of frailty on all-cause mortality and major bleeding in patients with atrial fibrillation: A meta-analysis","volume":"73","author":"He","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s41999-021-00537-w","article-title":"Atrial fibrillation: a geriatric perspective on the 2020 ESC guidelines","volume":"13","author":"Polidori","year":"2022","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0026","article-title":"Newly diagnosed atrial fibrillation is an independent factor for future major adverse cardiovascular events","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0027","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejim.2020.04.012","article-title":"Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study","volume":"78","author":"Rold\u00e1n Rabad\u00e1n","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0028","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11739-015-1326-1","article-title":"Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score","volume":"11","author":"Pastori","year":"2016","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0029","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003347","article-title":"Atrial fibrillation and myocardial infarction: A systematic review and appraisal of pathophysiologic mechanisms","volume":"5","author":"Violi","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0030","doi-asserted-by":"crossref","first-page":"e13161","DOI":"10.1111\/eci.13161","article-title":"Effect of concomitant antiplatelet therapy in patients with nonvalvular atrial fibrillation initiating non-vitamin K antagonists","volume":"49","author":"Elvira Ruiz","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.amjcard.2023.06.105_bib0031","doi-asserted-by":"crossref","first-page":"e13069","DOI":"10.1111\/ijcp.13069","article-title":"Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality","volume":"72","author":"Rivera-Caravaca","year":"2018","journal-title":"Int J Clin Pract"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923005167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923005167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:08:22Z","timestamp":1762078102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914923005167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":27,"alternative-id":["S0002914923005167"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.06.105","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.06.105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}